Health & Biotech
Trajan is a global developer and manufacturer of analytical and life sciences products and devices founded to enable science that benefits people by enriching personal health through scientific tools and solutions. These products and solutions are used by laboratories in the analysis of biological, food, and environmental samples. Trajan has a portfolio and pipeline of new technologies which support the move towards decentralised, personalised data-based healthcare. Our products span the biological workflow, from point of sample collection through varied analytical methods and on to data interpretation.
Our customers include large multi‑national original equipment manufacturers (OEMs) in the analytical science industry, biopharmaceutical, food and contract research organisation (CRO) laboratories, scientific distribution businesses and end-user laboroatories. These customers work in the Clinical, Pharmaceutical, Environmental, Food and Safety segments. The products we supply are categorised broadly as analytical components and consumables that are used in chromatography for precise measurement and diagnostic anatomical pathology. We also have capital equipment and software products and services that link into chromatography workflows, and gas odorisation products.
As part of our innovative work we have microsampling products for blood and skin samples and a versatile modular liquid chromatography system that can be employed in a wide variety of tasks including pharmaceutical process control and PFAS (forever chemical) testing of soil and other biological samples.
Trajan is a global organisation of more than 600 people, with seven manufacturing sites across the US, Australia, Europe and Malaysia, and operations in Australia (HQ), the US, Asia, and Europe. This global footprint is scaled and strategically organised to provide capacity for growth, ensures reliable and flexible responsiveness, and is proximate to key customers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Health & Biotech
Aussie made: ASX firms boosting local health & medical manufacturing
Health & Biotech
Microcap with a Blue-Chip profile: Trajan Group is growing through key acquisitions, partnerships and collaborations
News
Market Highlights: Wall Street defies Powell’s hawkish comments; and 5 stocks to watch on the ASX today
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers love these ASX listed automotive and scientific instrument stocks
Health & Biotech
ASX Health Stocks: Trajan delivers another strong half as it upgrades guidance
News
Top 10 at 10: The ASX stocks sprinting and stumbling in early trade Monday
Health & Biotech
Check Up: Only two healthcare IPOs from 2021 are gaining ground, could the rest be buying opportunities?
Health & Biotech
ASX Health Stocks: Giant Sonic and small cap Probiotic roll out the record results
Health & Biotech
ASX Health Stocks: Trajan rattles the tin in further $5 million cap raise
Health & Biotech
ASX Health Stocks: Kazia Therapeutics gets crucial designation status from the US FDA
Health & Biotech
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements
Health & Biotech
ASX Health Stocks: Mesoblast responds to questions arising from US FDA meeting
News
Closing Bell: December on track to be the ASX’s second best month of 2021
Health & Biotech
Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021
Health & Biotech